期刊文献+

胸膜恶性间皮瘤临床病理分析 被引量:2

Clinical pathological analysis about pleural malignant mesothelioma
下载PDF
导出
摘要 目的 对胸膜恶性间皮瘤进行临床病理分析,提高诊断及治疗水平,减少误诊率。方法 收集1975~1999年诊治病例,复习X光、B超及细胞病理资料。结果 80%病人临床上有胸痛且进行性加重,并有胸腔积液。X光有局限性胸膜增厚,胸水显示出现恶性瘤细胞,病理切片有双向分化特点。结论 对中年人胸部剧烈疼痛伴有胸腔积液时,应首先考虑本瘤,该瘤的确诊应依赖临床、影像学及细胞病理学。 Objective Make clinical pathlogical analysis to pleural malignant mesothelioma, and enhance the diagnostic and therapeutic level, and reduce the mistake diagnosis rate. Methods Collect the cases diag- nosed and treated from 1975?999, review X-ray. B-type ultrasound and cellular pathologic data. Results above 80% patients have pectoralgia and demonstrate progressive aggravating, and have pleural hydrops. The character of X-ray shows that located pleural incrassation, and find malignant tumor cells in thorax water, and have the character of double differentiation in pathologic section. Conclusion If middle aged pa- tients have the sympton of drastical pain in chest and company with thorax hydrops, we should considerate this disease first, and the diagnosis of this kind of tumor should depend on clinic, image and cellular pa- thology.
出处 《肿瘤防治研究》 CAS CSCD 2002年第1期30-31,共2页 Cancer Research on Prevention and Treatment
关键词 恶性间皮瘤 鉴别诊断 治疗 细胞病理学 胸膜肿瘤 Malignant pleural mesothelioma Clinic Image Cellular pathology
  • 相关文献

参考文献2

二级参考文献4

  • 1钟南山,现代呼吸病进展,1994年
  • 2王国本,肺部疾病的活检术,1992年
  • 3孙延瑞,国外医学呼吸系统分册,1990年,10卷,98页
  • 4薛立福,中华内科杂志,1990年,30卷,409页

共引文献45

同被引文献15

  • 1[2]Weiss SW,Goldblum JR.Soft tissue tumors.第4版,北京:人民卫生出版社,2002:1063~84.
  • 2[3]Cury PM, Butcher DN, Fisher C, et al . Value of the mesothelium-associated antibodies thrombomodulin, cytokeratin5/6,calretinin, and CD44H in distinguishing epithelioid pleural mesothelioma from adenocarcinoma mestastic to the pleura. Mod Pathol, 2000,13(2): 107~12
  • 3[4]Attanoos RL, Webb R, Dojcinov SD, Gibbs AR. Malignant epithelioid mesothelioma: anti-mesothelial marker expression correlates with histological pattern. Histopathology, 2001, 39(6): 584~8.
  • 4[5]Clover J, Oates C, Edwards C. Anti-cytokeratm5/6: a positive marker for epithelioid mescthelioma. Histopathology, 1997,31: 140~3.
  • 5[6]Ordonez NG. The immunohistochemical diagnosis of epithelial mesothelioma. Hum Pathol, 1999,30: 313~23.
  • 6[7]Chu PG, Weiss LM. Expression of cytokeratin 5/6 in epithelial neoplasms: an immunohistochemical study of 509 cases. Mod Pathol,2002, 15(1) :6~10.
  • 7史育慧,廖松林.Calretinin鉴别有浆液渗出的间皮瘤或腺癌[J].诊断病理学杂志,2001,8(5):266.
  • 8[9]Miettinen M, Limon J, Niezabitowski A, Lasota J. Calretinin and other mesothelioma markers in synoval sarcoma: analysis of antigenic similarities and differences with malignant mesothelioma. Am J Surg Pathol,2001,25(5): 610~7.
  • 9[10]Miettinen M, Sarlomo-Rikala M. Expression of calretinin,thrombomoduIin, keratin 5, and mesothelin in lung carcinomas of different types: An immunohistochemical analysis of 596 tumors in comparison with epithelioid mesotheliomas of the pleura. AmJ Surg Pathol, 2003, 27(2): 150~8.
  • 10[11]Ordonez NG, The value of antibodies 44-3A6, SM3, MC, and thrombomodulin in differentiating epithelial pleural mesothelioma from lung adenocarcinoma: a comparative study with other commonly used antibodies. Am J Surg Pathol, 1997,21 ( 12):1399~408.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部